GENWORTH FINANCIAL INC GNW
Genworth Financial offers mortgage insurance products through its principal mortgage insurance subsidiaries. Genworth Financial also has start-up businesses whereby it offers fee-based services, advice, consulting and other aging-care services through CareScout Services and long-term care insurance products through CareScout Insurance.
In October 2025, Genworth Financial began selling an individual long-term care insurance product through its CareScout Insurance subsidiary, CareScout Insurance Company, and ceased sales of long-term care insurance products through Genworth Life Insurance Company ("GLIC"). GLIC and its subsidiaries, which are wholly-owned subsidiaries of Genworth Financial and are referred to together as "Closed Block" or our "legacy insurance subsidiaries," no longer offer or sell long-term care insurance, life insurance or annuity products. However, our legacy insurance subsidiaries will continue to service and manage their in-force blocks of business and may still issue a limited number of certificates under existing group long-term care insurance policies.
Valuation FY2025 figures against the last close
Annual financial statements
Income statement
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $7.30B | $7.29B | $7.49B | $7.50B | $7.82B | $8.28B | $7.71B | $7.90B | $7.51B | $8.37B |
| SG&A | $1.01B | $977.0M | $942.0M | $1.28B | $998.0M | $935.0M | $909.0M | $943.0M | $957.0M | $1.27B |
| Operating income | — | — | $41.0M | $818.0M | $474.0M | $310.0M | $355.0M | -$5.0M | $530.0M | -$316.0M |
| Interest expense | $105.0M | $115.0M | $118.0M | $106.0M | $160.0M | $195.0M | $231.0M | $256.0M | $266.0M | $337.0M |
| Pre-tax income | $433.0M | $595.0M | $303.0M | $1.36B | $1.11B | $928.0M | $521.0M | $137.0M | $127.0M | $320.0M |
| Income tax | $84.0M | $158.0M | $104.0M | $319.0M | $248.0M | $230.0M | $139.0M | $70.0M | $406.0M | $358.0M |
| Net income | $223.0M | $299.0M | $76.0M | $916.0M | $850.0M | $178.0M | $343.0M | $119.0M | $817.0M | -$277.0M |
| EPS, basic | 0.54 | 0.69 | 0.16 | 1.82 | 1.68 | 0.35 | 0.68 | 0.24 | 1.64 | -0.56 |
| EPS, diluted | 0.54 | 0.68 | 0.16 | 1.79 | 1.65 | 0.35 | 0.67 | 0.24 | 1.63 | -0.56 |
| Shares, diluted (wtd. avg.) | $414.0M | $439.4M | $474.9M | $510.9M | $514.7M | $511.6M | $509.7M | $500.4M | $501.4M | $498.3M |
Balance sheet
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $2.04B | $2.05B | $2.21B | $1.80B | $1.57B | $2.56B | $3.26B | $1.97B | $2.65B | $2.78B |
| Goodwill | — | — | — | — | — | — | — | — | — | $14.0M |
| Other intangibles | — | $197.0M | $198.0M | $203.0M | $143.0M | $271.0M | — | — | — | — |
| Total assets | $88.08B | $86.82B | $90.82B | $89.71B | $99.17B | $122.35B | $101.34B | $100.92B | $105.30B | $104.66B |
| Long-term debt | $1.51B | $1.52B | $1.58B | $1.61B | $1.90B | $3.40B | $3.28B | $3.71B | $4.22B | $4.18B |
| Total liabilities | $78.32B | $77.44B | $82.48B | $81.33B | $82.91B | $120.27B | $86.71B | $86.73B | $89.97B | $90.19B |
| Retained earnings | $1.68B | $1.46B | $1.21B | $1.14B | $2.49B | -$626.0M | $1.46B | $1.12B | $1.11B | $287.0M |
| Total equity | $8.75B | $8.44B | $8.29B | $8.34B | $4.29B | $1.57B | $14.63B | $14.19B | $15.33B | $14.47B |
Cash flow
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $327.0M | $88.0M | $597.0M | $1.05B | $437.0M | $1.96B | $2.08B | $1.63B | $2.55B | $1.87B |
| Depreciation and amortisation | $231.0M | $249.0M | $264.0M | $326.0M | $384.0M | $463.0M | $408.0M | $348.0M | $392.0M | $498.0M |
| Stock-based compensation | $58.0M | $51.0M | $49.0M | $37.0M | $40.0M | $39.0M | $26.0M | $35.0M | $31.0M | $32.0M |
| Investing cash flow | $518.0M | $861.0M | $1.26B | $733.0M | $896.0M | -$1.15B | $1.30B | -$622.0M | -$759.0M | -$2.12B |
| Financing cash flow | -$857.0M | -$1.11B | -$1.44B | -$1.55B | -$2.42B | -$1.51B | -$2.22B | -$1.62B | -$1.77B | -$2.95B |
| Buybacks | $247.0M | $189.0M | $296.0M | $64.0M | $0 | $0 | — | — | — | — |
Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001276520-26-000019.
Others in SIC 6311
| Ticker | Company | Market cap | P/E | Revenue growth |
|---|---|---|---|---|
| MET | METLIFE INC | $62.04B | 20.7x | 8.5% |
| PRU | PRUDENTIAL FINANCIAL INC | $42.10B | 12.2x | -13.7% |
| RGA | REINSURANCE GROUP OF AMERICA INC | $16.54B | 14.3x | 7.2% |
| CRBG | Corebridge Financial, Inc. | $15.37B | — | -1.2% |
| GL | GLOBE LIFE INC. | $13.39B | 12.4x | 3.7% |
| JXN | Jackson Financial Inc. | $9.52B | — | 104.3% |
| VOYA | Voya Financial, Inc. | $9.43B | 16.5x | 4.9% |
| PRI | Primerica, Inc. | $9.10B | 12.9x | 6.6% |